Boston Scientific (BSX) Operating Expenses (2009 - 2026)

Boston Scientific's Operating Expenses history runs 18 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

• In Q1 2026, Operating Expenses rose 9.83% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $10.5 billion (up 13.74% YoY), while the FY2025 annual figure was $10.2 billion, up 15.24% from the prior year.
• Operating Expenses came in at $2.5 billion for Q1 2026 at Boston Scientific, down from $2.9 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.9 billion in Q4 2025 to a low of $1.6 billion in Q1 2022.
• A 5-year average of $2.1 billion and a median of $2.0 billion in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses dropped 7.34% in 2022 and advanced 24.87% in 2024, its largest moves.
• Boston Scientific's Operating Expenses stood at $1.8 billion in 2022, then increased by 9.02% to $2.0 billion in 2023, then grew by 21.3% to $2.4 billion in 2024, then rose by 17.93% to $2.9 billion in 2025, then declined by 11.95% to $2.5 billion in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $2.5 billion, $2.9 billion, and $2.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison